Iris M. Otani

1.7k total citations
50 papers, 821 citations indexed

About

Iris M. Otani is a scholar working on Pharmacology, Rheumatology and Immunology and Allergy. According to data from OpenAlex, Iris M. Otani has authored 50 papers receiving a total of 821 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pharmacology, 15 papers in Rheumatology and 13 papers in Immunology and Allergy. Recurrent topics in Iris M. Otani's work include Drug-Induced Adverse Reactions (25 papers), Urticaria and Related Conditions (13 papers) and Food Allergy and Anaphylaxis Research (13 papers). Iris M. Otani is often cited by papers focused on Drug-Induced Adverse Reactions (25 papers), Urticaria and Related Conditions (13 papers) and Food Allergy and Anaphylaxis Research (13 papers). Iris M. Otani collaborates with scholars based in United States, Argentina and France. Iris M. Otani's co-authors include Aleena Banerji, Mariana Castells, Lisa Beppu, Ranjan Dohil, Robert Newbury, Arjun Andrew Anilkumar, David H. Broide, Seema S. Aceves, Kari C. Nadeau and Johnson T. Wong and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Advances in experimental medicine and biology and Clinical Immunology.

In The Last Decade

Iris M. Otani

41 papers receiving 804 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iris M. Otani United States 15 277 218 216 192 174 50 821
Bob Geng United States 14 142 0.5× 111 0.5× 53 0.2× 62 0.3× 43 0.2× 52 492
Saira Z. Sheikh United States 11 218 0.8× 326 1.5× 47 0.2× 288 1.5× 89 0.5× 44 719
Rémi Gagnon Canada 13 63 0.2× 281 1.3× 61 0.3× 83 0.4× 39 0.2× 35 550
Maher Issa United States 19 120 0.4× 73 0.3× 29 0.1× 493 2.6× 47 0.3× 26 965
Nicolas Bachot France 10 112 0.4× 45 0.2× 685 3.2× 451 2.3× 55 0.3× 17 963
Vincent Descamps France 9 252 0.9× 35 0.2× 1.1k 5.1× 764 4.0× 62 0.4× 13 1.3k
Schmutz Jl France 12 30 0.1× 38 0.2× 78 0.4× 95 0.5× 101 0.6× 94 486
Zoltán Szekanecz Hungary 12 144 0.5× 35 0.2× 27 0.1× 279 1.5× 74 0.4× 24 653
Sandhia Ponnarambil United States 7 372 1.3× 365 1.7× 26 0.1× 117 0.6× 267 1.5× 30 1.5k
K. Shah United States 11 578 2.1× 19 0.1× 30 0.1× 372 1.9× 99 0.6× 25 917

Countries citing papers authored by Iris M. Otani

Since Specialization
Citations

This map shows the geographic impact of Iris M. Otani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris M. Otani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris M. Otani more than expected).

Fields of papers citing papers by Iris M. Otani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris M. Otani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris M. Otani. The network helps show where Iris M. Otani may publish in the future.

Co-authorship network of co-authors of Iris M. Otani

This figure shows the co-authorship network connecting the top 25 collaborators of Iris M. Otani. A scholar is included among the top collaborators of Iris M. Otani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris M. Otani. Iris M. Otani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blumenthal, Kimberly G., Andrew King, Elizabeth H. Phillips, et al.. (2025). The drug allergy history tool (DAHT): Validation of a patient-reported survey instrument. Journal of Allergy and Clinical Immunology. 156(3). 734–742.
2.
Otani, Iris M., et al.. (2024). A second look at secondary hypogammaglobulinemia. Annals of Allergy Asthma & Immunology. 134(3). 269–278.
3.
Khan, David A., Elizabeth J. Phillips, Alexei Gonzalez‐Estrada, et al.. (2023). United States Drug Allergy Registry (USDAR) grading scale for immediate drug reactions. Journal of Allergy and Clinical Immunology. 152(6). 1581–1586. 13 indexed citations
4.
Bhutani, Tina, et al.. (2023). Dupilumab as Adjunct Treatment for Persistent Food Allergy in Adulthood. Clinical Immunology. 250. 109461–109461. 1 indexed citations
5.
Ramsey, Allison, Upeka Samarakoon, Elizabeth J. Phillips, et al.. (2023). Drug allergy in older adults. Annals of Allergy Asthma & Immunology. 131(5). 628–636.e2. 10 indexed citations
6.
Otani, Iris M., et al.. (2023). Hereditary alpha tryptasemia presenting as recurrent chemotherapy hypersensitivity reactions. Annals of Allergy Asthma & Immunology. 132(3). 270–273. 1 indexed citations
7.
Fung, Monica, et al.. (2020). Zoonotic coronavirus epidemics. Annals of Allergy Asthma & Immunology. 126(4). 321–337. 7 indexed citations
8.
Anstey, James, et al.. (2019). Perioperative Use and Safety of Cephalosporin Antibiotics in Patients with Documented Penicillin Allergy. Journal of Allergy and Clinical Immunology. 143(2). AB29–AB29. 3 indexed citations
9.
Otani, Iris M., Alexi Otrakji, Niki S. Holtzman, et al.. (2018). Impact of a Novel Radiocontrast Media Reaction Treatment Algorithm in Simulation Settings of Anaphylaxis. Journal of Allergy and Clinical Immunology. 141(2). AB34–AB34.
10.
Otani, Iris M., Ryan W. Carroll, Phoebe H. Yager, et al.. (2018). Diffuse cutaneous mastocytosis with novel somatic KIT mutation K509I and association with tuberous sclerosis. Clinical Case Reports. 6(9). 1834–1840. 9 indexed citations
11.
Busse, Paula J., Sandra C. Christiansen, Jessica Overbey, et al.. (2018). Development of a health-related quality of life instrument for patients with hereditary angioedema living in the United States. The Journal of Allergy and Clinical Immunology In Practice. 7(5). 1679–1683.e7. 22 indexed citations
12.
Otani, Iris M., et al.. (2018). Cutaneous Manifestations of Reactions to Biologics. Current Allergy and Asthma Reports. 18(2). 12–12. 13 indexed citations
13.
Otani, Iris M. & Kari C. Nadeau. (2017). Biologic Therapies for Immunoglobulin E–mediated Food Allergy and Eosinophilic Esophagitis. Immunology and Allergy Clinics of North America. 37(2). 369–396. 7 indexed citations
14.
Barmettler, Sara, Iris M. Otani, Roshini S. Abraham, et al.. (2017). Gastrointestinal Manifestations in X-linked Agammaglobulinemia. Journal of Clinical Immunology. 37(3). 287–294. 43 indexed citations
15.
Otani, Iris M. & Aleena Banerji. (2016). Immediate and Delayed Hypersensitivity Reactions to Proton Pump Inhibitors: Evaluation and Management. Current Allergy and Asthma Reports. 16(3). 17–17. 21 indexed citations
16.
Otani, Iris M., Sandra C. Christiansen, Paula J. Busse, et al.. (2016). Emergency Department Management of Hereditary Angioedema Attacks: Patient Perspectives. The Journal of Allergy and Clinical Immunology In Practice. 5(1). 128–134.e4. 17 indexed citations
17.
Otani, Iris M., Philippe Bégin, Tina Dominguez, et al.. (2014). Multiple-allergen oral immunotherapy improves quality of life in caregivers of food-allergic pediatric subjects. Allergy Asthma and Clinical Immunology. 10(1). 25–25. 57 indexed citations
18.
Otani, Iris M., Arjun Andrew Anilkumar, Robert Newbury, et al.. (2013). Anti–IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis. Journal of Allergy and Clinical Immunology. 131(6). 1576–1582.e2. 126 indexed citations
19.
Kashiwakura, Jun‐ichi, Iris M. Otani, & Toshiaki Kawakami. (2011). Monomeric IgE and Mast Cell Development, Survival and Function. Advances in experimental medicine and biology. 716. 29–46. 35 indexed citations
20.
Akiyama, Takayuki, et al.. (1978). [Renal disease in the nail-patella syndrome: report of an affected family and studies of renal disease susceptibility and HLA (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 20(8). 909–20. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bob Geng Breakdown of academic impact, for papers by Saira Z. Sheikh Breakdown of academic impact, for papers by Rémi Gagnon Breakdown of academic impact, for papers by Maher Issa Breakdown of academic impact, for papers by Nicolas Bachot Breakdown of academic impact, for papers by Vincent Descamps Breakdown of academic impact, for papers by Schmutz Jl Breakdown of academic impact, for papers by Zoltán Szekanecz Breakdown of academic impact, for papers by Sandhia Ponnarambil Breakdown of academic impact, for papers by K. Shah
Rankless by CCL
2026